Vertex Pharmaceuticals (VRTX) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -200.00 |
| Dec 31, 2025 | -213.00 |
| Sep 30, 2025 | -138.00 |
| Jun 30, 2025 | -164.00 |
| Mar 31, 2025 | -238.00 |
| Dec 31, 2024 | 10,421.00 |
| Sep 30, 2024 | -28.00 |
| Jun 30, 2024 | 36.00 |
| Mar 31, 2024 | -166.00 |
| Dec 31, 2023 | -56.00 |
| Sep 30, 2023 | 135.00 |
| Jun 30, 2023 | 150.00 |
| Mar 31, 2023 | -6.00 |
| Dec 31, 2022 | 60.00 |
| Sep 30, 2022 | 21.00 |
| Jun 30, 2022 | 117.00 |
| Mar 31, 2022 | -514.00 |
| Dec 31, 2021 | 107.00 |
| Sep 30, 2021 | 107.00 |
| Jun 30, 2021 | -234.00 |
| Mar 31, 2021 | 135.00 |
| Dec 31, 2020 | 280.00 |
| Sep 30, 2020 | -210.00 |
| Jun 30, 2020 | -283.00 |
| Mar 31, 2020 | -356.00 |
| Dec 31, 2019 | -11,094.00 |
| Sep 30, 2019 | -644.00 |
| Jun 30, 2019 | -653.00 |
| Mar 31, 2019 | -384.00 |
| Dec 31, 2018 | -374.00 |
| Sep 30, 2018 | -514.00 |
| Jun 30, 2018 | -419.00 |
| Mar 31, 2018 | -175.00 |
| Dec 31, 2017 | 973.00 |
| Sep 30, 2017 | -347.00 |
| Jun 30, 2017 | 1,191.00 |
| Mar 31, 2017 | 33.00 |
| Dec 31, 2016 | -893.00 |
| Sep 30, 2016 | -458.00 |
| Mar 31, 2016 | -1,251.00 |
| Jun 30, 2015 | -928.00 |